I am a senior clinical scientist and drug development professional with over three decades of experience leading early-phase research at some of the world's most
respected pharmaceutical organizations - AstraZeneca, Novartis, Daiichi Sankyo, and Bristol Myers Squibb.

​

Through Phase 1 Solutions, LLC, I provide purpose-built consulting for sponsors and CROs who need a seasoned hand on their early-phase programs - whether that's building something right from the start, or rescuing a study that's in trouble.

​

My approach integrates clinical science, hands-on monitoring, and end-to-end operations into a unified, safety-first, inspection-ready engagement that is
indistinguishable from an in-house function.